Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01750671
Other study ID # CHU-0127
Secondary ID
Status Not yet recruiting
Phase N/A
First received November 16, 2012
Last updated December 13, 2012
Start date December 2012
Est. completion date December 2015

Study information

Verified date December 2012
Source University Hospital, Clermont-Ferrand
Contact Patrick LACARIN
Phone 04 73 75 11 95
Email placarin@chu-clermontferrand.fr
Is FDA regulated No
Health authority France: Ministry of Health
Study type Observational

Clinical Trial Summary

It is established that the surviving patients after a stay in the ICU are characterized by frequent malnutrition and morbidity and mortality. The main goal of this work is to study the relationship between nutritional statuses during ICU hospitalization, whatever its determinants, and quality of life, morbidity and mortality at one year.

The hypothesis of the study is that the presence of under nutrition is responsible for a 10% increase in crude mortality at one year (which would be respectively 30% for malnourished patients and 20% for non-malnourished patients).


Description:

This is a multicenter cohort study of a 30-month follow-up on patients after a stay in ICU.

Nutritional parameters and evaluation of the quality of life will be collected during hospitalization and output during a visit to the Clinical Research Associate at 6 months and one year. Survival will be also noted. These parameters will be studied in comparative patients malnourished and non-malnourished.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 680
Est. completion date December 2015
Est. primary completion date May 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients of both sexes, age greater than or equal to 18 years

- Hospitalized more than 72 hours in the ICU

- Requiring at least one support organ failure:

1. Ventilatory support (invasive or noninvasive)

2. Administration of catecholamines

3. Extrarenal purification whatever technique

- Affiliated to a social security system

- Having given free, informed written consent

Exclusion Criteria:

- Patients with end-stage disease or for which a limitation of care was decided

- Pregnant women

- Patients with minor or under guardianship

- Incapacitated adults and psychiatric inpatients

Study Design

Observational Model: Cohort


Related Conditions & MeSH terms

  • Nutritional Status at the Release of ICU.

Locations

Country Name City State
France Chu de Clermont-Ferrand Clermont-Ferrand

Sponsors (5)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand Baxter S.A.S, Hospices Civils de Lyon, Nestlé Healthcare Nutrition, University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary all-cause mortality at one year Yes
Secondary Anxiety and depression at inclusion, M6 and M12 Yes
Secondary Post-traumatic stress at inclusion, M6 and M12 Yes
Secondary Quality of life at M6 and M12 Yes
Secondary Degree of activity (Karnofsky questionnaire) At M6 and M12 Yes
Secondary Weight at inclusion, M6 and M12 Yes
Secondary Body mass index at inclusion, M6 and M12 Yes
Secondary Albumin at inclusion, M6 and M12 Yes
Secondary Orosomucoid at inclusion, M6 and M12 Yes
Secondary Transthyretin (prealbumin) at inclusion, M6 and M12 Yes
Secondary Body composition at inclusion, M6 and M12 Yes